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from studies in females. The present study examined bone structure and function over an 18-month period in
male C57BL/6 mice maintained on either a rodent chow diet (AIN76A) or a high-fat, Western-style diet
(HFWD). Effects of mineral supplementation were assessed in both diets.
Methods: Trabecular and cortical bone structure in femora and vertebraewere assessed bymicro-CT analysis. Fol-
lowing this, bone stiffness and strength measurements were made. Finally, bone levels of several cationic trace
elements were quantiﬁed, and serum biomarkers of bone metabolism evaluated.
Results: Bone loss occurred over time in both diets but was more rapid and extensive in mice on the HFWD. Di-
etary mineral supplementation reduced bone loss in both diets and increased bone stiffness in the femora and
bone stiffness and strength in the vertebrae. Bone content of strontiumwas increased in response tomineral sup-
plementation in both diets.
Conclusions: Bone losswasmore severe inmice on theHFWDandmineral supplementationmitigated the effects
of the HFWD. In comparison to previous ﬁndings with female C57BL/6 mice, the present studies indicate that
males are more sensitive to diet and beneﬁted from a healthy diet (AIN76A), while females lost as much bone
on the healthy diet as on the HFWD. Male mice beneﬁted from mineral supplementation, just as females did in
the previous study.
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Osteoporosis1. Introduction
Osteoporosis is commonly thought of as a disease of post-meno-
pausal women, but approximately 20% of cases and 30% of the osteopo-
rosis-related bone fractures in Western societies occur in men
(Guggenbuhl, 2009; Gielen et al., 2011; Adler, 2014). Additionally, oste-
oporosis and its consequences are rising rapidly in men, and while men
suffer fewer osteoporosis-related fractures thanwomen, several studies
have conﬁrmed that the consequences of fragility-related bone frac-
tures tend to be more severe in men than women (De Laet et al.,
1998; Center et al., 1999; Johnell & Kanis, 2006). In spite of the profound
consequences of osteoporosis in men, our understanding of the disease
in men is based, largely, on extrapolation of ﬁndings in women.ensional; AIN76A, American
e; AQ, Aquamin®; BMD, bone
8, Caudal 8 (vertebra); GRAS,
tyle diet; ICP-OES, Inductively
Micro-CT, micro-computed
he University of Michigan, 1301
).
. This is an open access article underGenetic and environmental factors inﬂuence bone growth and loss
in both women and men. Among environmental factors, diet is critical.
Past studies have demonstrated that a high-fat diet promotes bonemin-
eral loss and increases bone fragility (von Muhlen et al., 2007; Prentice,
2004; Rosen & Klibanski, 2009). The Western-style diet may be espe-
cially permissive because in addition to its high content of saturated
fat and processed carbohydrate, the Western diet is also low in calcium
(US Department of Agriculture, 2015; Peterlik & Cross, 2005) and other
minerals that are nutritionally associated with calcium. Calcium is the
major cationic mineral in bone, and an adequate supply of dietary calci-
um throughout life is critical to the formation and maintenance of
healthy bone tissue (Heaney & Weaver, 2005; Peacock et al., 2000).
What role other cationicminerals play is not aswell understood, but ad-
equate levels of several trace elements including boron, copper, chromi-
um, magnesium, manganese, selenium, silicon, strontium and zinc are
considered important for bone health (Odabasi et al., 2008; Lowe
et al., 2002; Strause et al., 1994; Jugdaohsingh, 2007; Marie et al.,
2001; Cashman & Flynn, 1998; Yamaguchi, 1998).
Rodents have been used to study various aspects of bone formation
and loss. In rodents, as in humans, bone formation occurs rapidly during
early post-natal development (in mice, through at least 2 months of
age). Thereafter, trabecular bone is gradually lost. Net cortical bonethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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loss remain relatively stable (Boskey & Coleman, 2010). As true for
humans, past studies have demonstrated that a high-fat diet contributes
to bone mineral loss and increases bone fragility (i.e., promotes the os-
teoporotic phenotype) (Zernicke et al., 1995; Pelton et al., 2012;
Parhaml et al., 2001; Glatt et al., 2007; Ward et al., 2003). Our own
past studies carried out with female C57BL/6 mice demonstrated that
trabecular bone loss occurred rapidly (within 5 months) in animals
fed a Western-style diet and continued over an 18-month period
(Aslam et al., 2010a; Aslam et al., 2013). Surprisingly, however, rapid
bone loss was also seen in mice fed a low-fat rodent chow diet. When
either diet was supplemented with a calcium-rich, multi-mineral natu-
ral product, Aquamin® (AQ), bone losswas substantially mitigated. The
present study was carried out to assess effects of diet and mineral sup-
plementation on bone structure/function in male C57BL/6 mice main-
tained on the same Western-style diet or on the same rodent chow
diet as used previously with female mice. Findings from the present
study with male mice are signiﬁcantly different from results obtained
previously with females (Aslam et al., 2013). Whereas female mice
lost bone mass and bone strength on either diet, in male mice, bone
structure and function were largely preserved over an 18-month time-
period on the healthy, rodent chow diet (AIN76A). In males, bone loss
was seen, primarily, in animals on the HFWD. In spite of this difference,
mineral supplementation mitigated bone loss in males, just as it did in
females.
2. Materials and methods
2.1. Mineral supplement
Aquamin® (AQ) was used to provide mineral supplementation. The
mineral supplement is obtained from the skeletal remains of the red
marine algae, Lithothamnion sp. (Aslam et al., 2010a; Aslam et al.,
2013). AQ is approximately 15% calcium and 1.5% magnesium by
weight, and also contains measurable levels of 72 additional trace min-
erals - essentially all of the minerals that the algae are able to gather
from the marine water. AQ (GRAS 000028) is used in various products
for human consumption in Europe, Asia, Australia, and North America
[Marigot Ltd., Cork, IR]. The complete mineral composition of AQ (as
assessed by Advanced Laboratories, Inc., Salt Lake City, UT) can be
found in Supplement Table 1.
2.2. Mice and diet groups
In this study, 140 male C57BL/6 mice (Charles River, Portage, MI)
were started at 3-weeks of age on either a standard rodent chow diet
(AIN76A) or on a high-fat diet Western diet (HFWD) prepared accord-
ing to the formulation of Newmark (Newmark et al., 2009). This variant
of AIN76A is designed to mimic food consumption patterns common in
Western society (US Department of Agriculture, 2015; Peterlik & Cross,
2005). The HFWD contains 20% fat from corn oil as compared to 5% in
AIN76A. The percentage of calories from fat in this diet is 37.8% as com-
pared to 11.5% in the AIN76A diet. Although sucrose is reduced relative
to the amount in AIN76A, the overall calories provided in the HFWD is
4764 kcal% versus 3902 kcal% in AIN76A. In addition to its high fat con-
tent, the HFWD has additional modiﬁcations. Methionine is replaced
with cysteine, amounts of ﬁber, folic acid and choline are reduced, and
the total calcium level is reduced from approximately 5.25 g per kg to
0.41 g per kg. Both AIN76A and its high-fat variant contain a mix of es-
sential trace elements including potassium, magnesium, manganese,
chromium, copper, iron, selenium, sodium and zinc as part of the
AIN76A formulation. For half of the animals on either diet, the calci-
um-rich, multi-mineral supplement (AQ) was included at 62 g per
1.062 kg of diet. At this concentration of AQ, the dietary calcium provid-
ed to animals on the HFWD is approximately 6.9 g per kg. The slightly
increased calcium (relative to the amount in AIN76A) is based on thepremise that mice on high fat diet will consume less food than animals
on the corresponding lower fat diet (AIN76A).
From each diet group, 10 mice were euthanized after 5 months and
12 months, and 15mice were euthanized after 18 months. A group of 5
mice were euthanized at the start of the study to provide baseline
values. Diets were formulated and provided by Research Diets Incorpo-
rated (New Brunswick, NJ). The complete composition of each diet is
presented in Supplement Table 2. Food and water were provided ad
libitum. Animals were monitored at 2-day intervals throughout the in-
life phase and were weighed at 2-week intervals. All of the procedures
were reviewed and approved by the University Committee on Use and
Care of Animals (UCUCA) at the University of Michigan.
2.3. Preparation of skeletal tissue and micro-computed tomography
(micro-CT)
At euthanasia, the left femora and the C8 caudal vertebrae were
carefully dissected free of associated connective tissue, immediately
placed in sealed containers with lactated Ringer's solution, and frozen
at -20 °C until use. Three-dimensional images of regions of interest
(ROI) were obtained using a micro-CT system (eXplore Locus SP, GE
Healthcare Pre-Clinical Imaging, London, Ontario, Canada) as previously
described and validated (Meganck et al., 2009; Bouxsein et al., 2010). In
the present study, we followed the same procedure as used in our pre-
vious studieswith femalemice (Aslam et al., 2013). A complete descrip-
tion of themicro-CT imaging procedure can be found in the Supplement
under Methodology.
2.4. Biomechanical testing
Mechanical properties of the femora were determined by loading
the left femora to failure in 4-point bending, exactly as described previ-
ously with female mice (Aslam et al., 2013). Three parameters –
stiffness, post-yield displacement ratio (i.e., displacement at failure –
displacement at yield) and maximum load were determined as
described previously (Turner, 2006; Peterlik et al., 2006). Stiffness was
deﬁned as the slope of the linear region of the pre-yield load-displace-
ment curve, and the yield point was deﬁned as the point where the
load-displacement curve intersected with a regression line that was
10% lower than that used to deﬁne stiffness.Maximum loadwas deﬁned
as the load at which the bone catastrophically failed.
Mechanical properties of intact caudal vertebrae were measured by
compressing the vertebral body with a 3 mm diameter platen attached
to a servohydraulicmaterials-testingmachine as described in our earlier
study (Salem et al., 1993; Tommasini et al., 2008). In the compression
tests, the cranial and caudal endplates of the caudal vertebrae were
not altered prior to testing. Parameters assessed included stiffness and
maximum load. Stiffness was deﬁned as the slope of the linear region
of the pre-yield load-displacement curve and maximum load was de-
ﬁned as the highest load preceding a rapid decrease in the measured
load (i.e., catastrophic failure).
2.5. Levels of individual trace elements in long bones
Following micro-CT and biomechanical testing on femora, the long
bones (one femur and tibia from all animals in each group) were
“pooled” by group and time point, and analyzed for levels of various
trace metals. The C8 vertebrae from all the animals in a group were
also tested as a group. Bones were “pooled” in order to have a sufﬁcient
amount of material to obtain a detectable signal with several of the
minor trace elements thought to be important to bone. Bones were
digested in a concentrated nitric acid solution (10ml) for approximately
30min, after which theywere cooled to room temperature. Concentrat-
ed hydrochloric acid (10 ml) was added and the sample was digested
for an additional 15 min. After cooling and dilution with distilled
water, levels of individual trace elements were determined by
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Bone preparation and assays were done on a fee-for-service by Ad-
vanced Laboratories, Inc. Sensitivity by this method is 0.5 μg/g.
2.6. Tartrate-resistant acid phosphatase (TRAP) and N-terminal peptide of
type I procollagen (P1NP)
Blood was obtained at the time of necropsy from each animal. TRAP
and P1NP were assessed in serum samples using commercially-avail-
able enzyme-linked immunosorbent assays (ELISAs) (Immunodiagnos-
tic Systems, Inc.; Fountain Hills, AZ). TRAP is produced by osteoclasts
and macrophages and can be detected in serum. The ELISA used here
measures TRAP 5b, the form speciﬁc to osteoclasts (Hannon et al.,
2004). TRAP 5b is thought to be a measure of osteoclast number rather
than activity. P1NP is ameasure of osteoblast function. Type I collagen is
the major collagenous protein in bone (Risteli & Risteli, 2006).
2.7. Data presentation and statistical evaluation
Data from micro-CT analysis and biochemical evaluations were ob-
tained for individual mice. The data were presented as group averages
and standard deviations. Differences among groups were compared
for statistical signiﬁcance using ANOVA followed by paired group com-
parisons (two-tailed). Differences were considered signiﬁcant at the
p b 0.05 level. Trace element assessment was done on bones that were
“combined” from all the mice in a group in order to have a sufﬁcient
amount for assessment ofminor trace elements.While individual “com-
bined” samples could not be analyzed statistically, the data for each
mineral from the three different time-points (long bones only) were
subjected to two-way factorial ANOVA followed by paired group com-
parison, to determine if the effect of time was signiﬁcant. Where the
criteria were met (time not a signiﬁcant variable), data from the three
time points were grouped together and analyzed. Differences were con-
sidered signiﬁcant at the p b 0.05 value.
3. Results
3.1. Animal weight and survival data
At the initiation of study, mice had an average weight of 10 ± 1 g.
Over the 18-month period, animals gained weight on both diets. Ani-
mals in the AIN76A diet groups (with or without AQ) had weights of
42 ± 6 g and 45 ± 4 g at 18-month time-point. As expected, animals
on the HFWD gained more weight than animals on AIN76A, but AQ
had no effect on weight gain (51 ± 8 g in HFWDwithout AQ compared
to 52 ± 6 g with the AQ). Previous studies have suggested that dietary
calcium supplementation can help to control weight-gain under some
conditions (Bastie et al., 2012; Pilvi et al., 2007). Neither the present
study, nor our previous study with female mice (Aslam et al., 2010a;
Aslam et al., 2013), demonstrated this capacity of calcium with either
the standard rodent chow diet or the high-fat diet.
Over the entire course of the 18-month maintenance period, 11 an-
imals died or were euthanized for humane reasons. Of these, 9 were on
the HFWDwithout supplementation and 2were on the HFWDwith the
mineral supplement. Bones from animals that died prematurely were
handled as part of their respective cohort. Serum calcium levels obtain-
ed at euthanasia were 9.9 ± 1.3 and 10.6 ± 1.1 mg per dl in mice on
AIN76A without and with AQ compared to 9.5 ± 1.2 and 10.1 ±
0.7 mg per dl in mice on the HFWD without and with AQ.
3.2. Femoral bone structure and function: effect of diet and mineral
supplementation
Micro-CT data from the trabecular ROI at 5, 12 and 18-month time-
points are shown in Fig. 1. It can be seen from the ﬁgure that BMD
remained almost constant over the 18-month maintenance period inmice on the rodent chow diet but declined by approximately 40% in
mice fed the HFWD as compared to mice fed HFWD plus AQ. BV/TV
and trabecular number declined in mice on either diet, but the decline
was more severe in mice on the HFWD (BV/TV: 79% reduction in
HFWD versus 48% in AIN76A; trabecular number: 77% decline versus
49% in the two diets, respectively). Trabecular thickness remained con-
stant over the 18-month time period on either diet.
Fig. 1 also demonstrates the effects of mineral supplementation on
trabecular bone parameters. Mineral supplementation improved each
of the trabecular bone parameters and this was observed in both diets.
Of interest, even though trabecular thickness (unlike the other parame-
ters) did not decline signiﬁcantly in either diet over the 18-month time-
period, AQ led to a statistically signiﬁcant increase in thickening in both
AIN76A and the Western style diet (33–35% increase).
Cortical bone parameters are presented in Fig. 2. In contrast to what
was seenwith trabecular bone (where there was a signiﬁcant decline in
structural features over time), cortical bone properties – speciﬁcally,
BMD and cortical area – increased in all groups between the beginning
of the study at 3-weeks of age and 5 months, and then remained stable
through the end of the study (18months). TheWestern style diet had a
negative effect on both parameters (both BMD and cortical area were
reduced by approximately 16% at the 18-month time-point in the
HFWD as compared to HFWD plus AQ). Mineral supplementation with
AQ reversed these HFWD-dependent deﬁcits in cortical bone (Fig. 2).
Femoral mechanical properties (bone ductility and strength) were
determined by subjecting bones to failure in 4-point bending (Fig. 3).
Response in the 4-point bending assay is largely a reﬂection of cortical
bone properties (Bouxsein et al., 2010). Consistent with differences in
cortical bone structural properties assessed by micro-CT (i.e., reduced
BMD, reduced cortical area and increased marrow area), bones from
mice on the unsupplemented HFWD were highly ductile (i.e., with re-
duced stiffness and high displacement ratio) as compared to bones
from mice maintained on the AIN76A diet. Consistent with our under-
standing of bone mechanics (Meganck et al., 2009; Bouxsein et al.,
2010; Turner, 2006; Peterlik et al., 2006), the high ductility of the fem-
ora of mice without mineral supplementation was associated with a
high load required for catastrophic failure. Mineral supplementation re-
duced bone ductility while having only a modest effect on bone
strength. In contrast to these results in HFWD-fedmice, mineral supple-
mentation hadminimal effect on long bone biomechanical properties in
mice maintained on the AIN76A diet. All of the micro-CT and biome-
chanical parameters from femora are presented in Supplement Tables
3–5.
3.3. Vertebral bone structure and function: Effect ofmineral supplementation
Although the present study was conducted, primarily, with femoral
bone, we also carried out a series of experiments with the C8 vertebrae
frommice on the HFWD at the 18-month time-point. Micro-CT data are
shown in Fig. 4A and 4B. In the trabecular ROI, BMD, BV/TV and trabec-
ular thickness were all increased signiﬁcantly at the 18-month time-
point relative to what was seen at 3 weeks of age. In the cortical ROI,
we observed signiﬁcant increases in BMD, cortical area and total area
at the 18-month time-point relative to what was seen at 3 weeks of
age. Mineral supplementation with AQ improved bone structural fea-
tures detected by micro-CT in both trabecular and cortical ROI relative
to what was observed in the absence of supplementation (Fig. 4A and
4B). Trabecular BMD was increased by 8% and cortical BMD was in-
creased by 18% in mice on themineral-supplemented diet as compared
to the unsupplemented HFWD (p b 0.05 for both). Cortical area was in-
creased by almost 37% in the mineral-supplemented HFWD relative to
the HFWD alone (p b 0.05).
Vertebral biomechanical properties (i.e., resistance to compression
load damage) were assessed following micro-CT analysis. Results in
the compression-damage assay are a reﬂection of both stiffness and
strength, and depend on both trabecular and cortical properties
Fig. 1. Femoral bone: Structural features of trabecular bone. Structural features were assessed in the trabecular ROI bymicro-CT as described in theMaterials andMethods. Data are based
on 5 mice at baseline (4 weeks of age), 10 mice at the 5 and 12 month time-points and 15 mice at the 18 month time-point in each group. Values are means and standard deviations.
Statistical signiﬁcance of each parameter was assessed by ANOVA followed by paired group comparisons. Statistical signiﬁcance at the p b 0.05 level is indicated by the letters “a”, “b”,
and “c”. The letter “a” above the HFWD + AQ bar indicates statistically signiﬁcant improvement relative to HFWD alone. The letter “b” above the HFWD + AQ bar indicates
statistically signiﬁcant improvement relative to AIN76A group. The letter “c” above the AIN76A + AQ bar indicates statistically signiﬁcant improvement relative to AIN76A alone. All of
the trabecular micro-CT parameters measured at the three time points are presented in Supplement Table 3. Insert: Representative 3D micro-CT images of the trabecular ROI from the
femora of mice in each diet group, at each time-point.
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stantially improved (48% increase with AQ compared to HFWD alone)
as was maximum load (41% increase in AQ compared to HFWD alone)
(p b 0.05 for both). All of the micro-CT and biomechanical parameters
from C8 vertebrae are presented in Supplement Tables 6 and 7.
3.4. Levels of individual trace elements in bone: effect of diet and mineral
supplementation
Following micro-CT analysis and biomechanical testing, bone calci-
um levels and levels of 11 cationic elements thought to be important
for bone health were assessed in femora at each of the three time-
points. Minerals included boron, copper, chromium, iron, magnesium,
manganese, potassium, selenium, silicon, strontium and zinc. The data
are presented in Table 1. As part of the analysis, levels of 30 additional
minerals prevalent in AQ were assessed in femoral bone (SupplementTables 8–10). To summarize the data from Table 1, bone calcium levels
frommice on the HFWD (with a calcium concentration of 0.41 g per kg)
were decreased by 3–9% as compared to bone calcium levels inmice fed
AIN76A (with a calcium concentration of 5.25 g per kg) (not signiﬁcant-
ly different). When AQ was included in the HFWD, bone calcium levels
were increased by 9, 13 and 7% at 5-, 12- and 18-month time-points, re-
spectively, as compared to HFWD alone. These levels are similar to
levels seen in AIN76Awithout supplementation. Levels of four elements
– boron, copper, chromium and selenium were below detectable limits
(0.5 μg/g) in all diet groups at all three time-points. Amongother cation-
ic elements, iron, manganese, silicon and zinc demonstrated a modest
but statistically signiﬁcant decrease in the presence of AQ versus
HFWD alone. Finally, and perhaps most interesting, strontium levels
were increased dramatically in bones of mice in response to mineral-
supplementation with AQ in both diet groups. This was observed with
both diets at all three time-points (Table 1). The same minerals were
Fig. 2. Femoral bone: Structural features of cortical bone. Structural features were assessed in the cortical ROI bymicro-CT as described in theMaterials andMethods. Data are based on 5
mice at baseline (4weeks of age), 10mice at the 5 and 12month time-points and 15mice at the 18month time-point in each group. Values aremeans and standard deviations. Statistical
signiﬁcance of each parameter was assessed by ANOVA followed by paired group comparisons. Statistical signiﬁcance at the p b 0.05 level is indicated by the letters “a”, “b”, and “c”. The
letter “a” above the HFWD+ AQ bar indicates statistically signiﬁcant improvement relative to HFWD alone. The letter “b” above the HFWD+ AQ bar indicates statistically signiﬁcant
improvement relative to AIN76A group. The letter “c” above the AIN76A + AQ bar indicates statistically signiﬁcant improvement relative to AIN76A alone. All of the cortical micro-CT
parameters measured at the three time points are presented in Supplement Table 4. Insert: Representative 3D micro-CT images of the cortical ROI from the femora of mice in each diet
group, at each time-point.
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Similar to what was seen with femora, only strontiumwas signiﬁcantly
increased by AQ (254 μg/g in supplemented HFWD versus 41 μg/g in
HFWD). Complete mineral analysis of C8 vertebrae is presented in
Supplement Table 11.
3.5. Serum TRAP and P1NP
TRAP-5b and P1NP levels are shown in Table 2. Consistent
with what we have seen previously in female C57BL/6 mice (Aslam et
al., 2010a; Aslam et al., 2013), levels of TRAP-5b were increased in
response to mineral supplementation with AQ in both diets at
all three time-points. Eighteen month values were statistically sig-
niﬁcant. Also consistent with what we have reported previously infemales, P1NP levels were not signiﬁcantly different between the sup-
plemented and unsupplemented diets at any of the three time-points
(Table 2).
4. Discussion
Osteoporosis affectsmenaswell aswomen, but femalesmakeup the
majority of people diagnosedwith the condition and suffer themajority
of osteoporotic bone fractures (Guggenbuhl, 2009; Gielen et al., 2011;
Adler, 2014). When ﬁndings from the current study in male mice are
taken in conjunction with our previous ﬁndings with female mice,
they allow us to conclude that while female mice lose bone over time
on both healthy and unhealthy diets, bone loss in males is, primarily, a
consequence of the (unhealthy) HFWD. To the extent that these
Fig. 3. Femoral bone: Biomechanical properties. Femoral stiffness and strengthwere assessed in the 4-point bending assay as described in theMaterials andMethods. Data are based on 5
mice at baseline (4weeks of age), 10mice at the 5 and 12month time-points and 15mice at the 18month time-point in each group. Values aremeans and standard deviations. Statistical
signiﬁcance of each parameter was assessed by ANOVA followed by paired group comparisons. Statistical signiﬁcance at the p b 0.05 level is indicated by the letters “a”, “b”, and “c”. The
letter “a” above the HFWD+ AQ bar indicates statistically signiﬁcant improvement relative to HFWD alone. The letter “b” above the HFWD+ AQ bar indicates statistically signiﬁcant
improvement relative to AIN76A group. The letter “c” above the AIN76A + AQ bar indicates statistically signiﬁcant improvement relative to AIN76A alone. All of the biomechanical
properties measured in femora at the three time points are presented in Supplement Table 5.
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eﬁt more than women from a life-time healthful diet. Perhaps the
higher incidence of osteoporosis in women reﬂects this.Fig. 4. Vertebral bone structure and function. A: Structural features of trabecular bone. B: Struct
18-month time-point in each group. Values aremeans and standarddeviations. Statistical signiﬁ
p b 0.05 level is indicated by the letter “a” above the HFWD+ AQ bar, which indicates statistic
shows the positive correlation between stiffness and strength in individual mice. All of the C
measured at the 18 month time-point are presented in Supplement Tables 6 and 7. Insert: A
from the C8 caudal vertebrae of a mouse in each diet group at zero time and 18 month (magnAn important aspect of the present study was determining the ex-
tent to which a calcium-rich, multi-mineral supplement could mitigate
the effects of the Western-style diet on bone structure and function inural features of cortical bone. C: Biomechanical properties. Data are based on 10mice at the
cance of eachparameterwas assessed using the Student t-test. Statistical signiﬁcance at the
ally signiﬁcant improvement relative to HFWD alone. The right lower panel (scatter plot)
8 vertebral micro-CT trabecular/cortical bone parameters and biomechanical properties
representative 3D micro-CT image of trabecular (surface) and cortical (diaphysis) region
iﬁcation bar = 1 mm).
Table 1
Cationic mineral content in femoral bone samples from mice in each diet group.
Mineral/diet group 5-months 12-months 18-months
Calcium
AIN76A 199,500 230,300 229,100
AIN76A + AQ 199,400 233,800 234,100
HFWD 193,100 215,900 204,800
HFWD + AQ 209,300 243,800 218,600
Iron
AIN76A 144 266 228
AIN76A + AQ 69 218 167
HFWD 380 331 327
HFWD + AQ 134 201 224a
Magnesium
AIN76A 3036 3192 3649
AIN76A + AQ 3250 3724 3797
HFWD 2927 3175 3243
HFWD + AQ 3208 3537 3770
Manganese
AIN76A 2.01 1.22 1.16
AIN76A + AQ 1.97 1.27 0.97
HFWD 7.20 4.44 3.56
HFWD + AQ 1.63 1.36 1.07a
Potassium
AIN76 759 1273 1458
AIN76A + AQ 724 1109 1227
HFWD 758 1172 1306
HFWD + AQ 903 1123 1245
Silicon
AIN76A 4.75 1.20 1.76
AIN76A + AQ b0.5 b0.5 0.81
HFWD 4.34 2.40 1.78
HFWD + AQ b0.5 b0.5 b0.5a
Strontium
AIN76A 50 25 25
AIN76A + AQ 210 260 237c
HFWD 112 66 44
HFWD + AQ 231 244 238a,b
Zinc
AIN76A 111 134 124
AIN76A + AQ 124 150 138
HFWD 246 232 198
HFWD + AQ 140 164 147a,b
Femora from all mice in a group were pooled together, digested and analyzed by ICP-OES, as one sample per group (10 mice per group at 5- and 12-months and 15 mice at 18-months).
Boron, copper, chromiumand seleniumwere belowdetectable limit (0.5 μg/g). The data for eachmineral from the three time-points grouped togetherwere subjected to two-way factorial
ANOVA followed by paired group comparisons. “a” and “b” are placed on the HFWD+AQ group: “a” shows statistically signiﬁcant difference relative to the HFWD group, and “b” shows
statistically signiﬁcant difference relative to AIN76A. A “c” is placed on the AIN76A + AQ group shows signiﬁcant difference relative to AIN76A alone (p b 0.05).
Table 2
Serum TRAP and P1NP levels.
Diet group 5-months 12-months 18 months
TRAP (U/ml)
AIN76A 0.6 ± 0.5 9.5 ± 2.62 5.9 ± 1.4
AIN76A + AQ 0.9 ± 0.5 16.0 ± 6.0 11.6 ± 3.9c
HFWD 0.4 ± 0.5 9.1 ± 5.6 7.8 ± 3.7
HFWD + AQ 1.1 ± 0.4 24.7 ± 11.2 10.1 ± 4.7a,b
P1NP (ng/ml)
AIN76A Not determ 20.3 ± 4.3 17.1 ± 3.4
AIN76A + AQ Not determ 17.7 ± 3.2 14.8 ± 3.9
HFWD Not determ 23.6 ± 5.8 21.2 ± 5.1
HFWD + AQ Not determ 20.1 ± 4.4 17.9 ± 6.2
Baseline TRAP=0.75±0.5U/ml. Values aremeans and standard deviations. N=10, 9 and 10 for AIN76A; 8, 10 and 10 for AIN+AQ; 9, 10 and 10 for HFWD and 10, 10 and 8 for HFWD+
AQ at 5, 12 and 18 months, respectively.
P1NP data at baseline and at 5 month - not available. N= 10 and 10 for AIN76A; 10 and 10 AIN+ AQ; 9 and 9 for HFWD and 10 and 8 for HFWD+AQ at 12 and 18months, respectively.
Statistical signiﬁcance was determined by ANOVA followed by paired group comparisons. “a” and “b” are placed on the HFWD+ AQ group: “a” shows statistically signiﬁcant increase
relative to the HFWD group, “b” shows statistically signiﬁcant increase relative to AIN76A; “c” is placed on the AIN76A+ AQ group, and shows signiﬁcant increase relative to the control
(p b 0.05).
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148 M.N. Aslam et al. / Bone Reports 5 (2016) 141–149male mice. In our previous studies with female mice (Aslam et al.,
2013), mineral supplementation reduced bone loss in either diet. Here
we demonstrate that the same multi-mineral supplement reduced
bone loss in both femora and vertebrae as compared to control. In
males, however, the effects were seen primarily in the HFWD, where
bone loss was more severe. It is reasonable to suggest based on these
data that a lack of dietary minerals contributes signiﬁcantly to bone de-
terioration seen by us [present report and (Aslam et al., 2010a; Aslam et
al., 2013)] and others (Zernicke et al., 1995; Pelton et al., 2012; Parhaml
et al., 2001; Glatt et al., 2007; Ward et al., 2003) in HFWD-fed rodents.
The consequences of the mineral deﬁciency to the negative impact of
a HFWD are not unique to bone. Previous studies showed that tumor
formation in the liver and colon were increased in mice on the same
HFWD as used here, and that both ill-effects were largely overcome
with mineral supplementation (Newmark et al., 2009; Aslam et al.,
2012a; Aslam et al., 2010b; Aslam et al., 2012b). To the extent that
these ﬁndings can be extrapolated to humans, the data emphasize the
importance of having an adequate supply of calcium and, perhaps,
other trace elements in the diet. TheWestern-style diet may be harmful
as much by what it lacks as what it contains.
An intriguing question is whether the beneﬁcial effects of themulti-
mineral supplement can be ascribed to its calcium content alone, or
whether one or more of the trace elements in the preparation contrib-
ute to bone health in ameaningfulway. Calcium is, by far, themajor cat-
ionic mineral in bone, and the necessity for an adequate supply of
dietary calcium throughout life is well-recognized. However, several
other cationic trace elements including boron, copper, chromium, iron,
magnesium, manganese, selenium, silicon, strontium and zinc have all
been suggested to play roles in bone health (Odabasi et al., 2008;
Lowe et al., 2002; Strause et al., 1994; Jugdaohsingh, 2007; Marie et
al., 2001; Cashman & Flynn, 1998; Yamaguchi, 1998). Calcium is the
most highly represented mineral in AQ but each of the other elements
is present at quantiﬁable levels (Supplement Table 1). It is not unrea-
sonable to suggest that one or several of these minerals could provide
added beneﬁt over and above that seen with calcium alone. In our two
previous studies conducted with female C57BL/6 mice (Aslam et al.,
2010a; Aslam et al., 2013), one of the comparisons was between mice
on the AIN76A diet without supplementation and HFWD-fed mice
with themineral supplement.While the two diets provided comparable
levels of calcium, female mice on the HFWD with the mineral supple-
ment fared better than mice on AIN76A without the supplement (in
terms of both structural and mechanical properties). Most of the
added beneﬁt appeared to be in trabecular bone. Using the same ap-
proach with male mice, we found a smaller (but still detectable)
added beneﬁt with AQ. Speciﬁcally, in male mice, femoral trabecular
thickness was greater in AQ-supplemented mice than in control mice
on either diet. How valuable the additional minerals will, ultimately,
prove to be in human bone health cannot be determined from the pres-
ent data. We are currently conducting a 90-day intervention biomarker
study (ClinicalTrials.gov Identiﬁer: NCT02647671; comparing AQ to
both placebo and calcium alone – randomized and double-blinded) in
human subjects with serum markers of bone turnover as one of the
endpoints.
One thing is clear from this study; the distribution of certain cationic
minerals in bones was affected by AQ-supplementation. Levels of iron,
manganese and zinc were higher in bones of HFWD-fed mice than in
AIN76A-fed mice. When the HFWD was supplemented with AQ, levels
of these trace elements declined. Perhaps,more interestingly, strontium
content increased several fold in response to AQ supplementation, and
thiswas observed in both diets. The increase in strontium is of particular
interest since strontium is known to replace calcium in bone, and
is thought to preserve bone microarchitecture and bone strength
(Marie et al., 2001; Meunier et al., 2004; Ammann et al., 2004). In
addition, strontium has been shown to alter osteoclast/osteoblast
function in vitro (Marie et al., 2001; Saidak & Marie, 2012) and so an
effect on bone remodeling mechanisms may contribute to its action –independent of incorporation into the crystalline structure, itself. It
would be unwise at this time to ascribe all of the added beneﬁt to stron-
tium because certain other minerals present in the multi-mineral sup-
plement are also known to affect osteoclast and osteoblast function
(Lowe et al., 2002; Yamaguchi, 1998). Currently, we are comparing cal-
cium along with various combinations of mineral salts (formulated to
the same relative amounts as present in themulti-mineral supplement)
to calcium alone in rodents on the HFWD.
In summary, we have previously studied bone changes in female
C57BL/6 mice maintained over an 18-month period on either a low-
fat rodent chow diet or a HFWD, and have assessed the effects of a cal-
cium-rich, multi-mineral supplement on bone structure and function in
both diets (Aslam et al., 2013). Our major conclusions from those stud-
ies were i) that signiﬁcant (and comparable) bone loss occurred over
time in either diet and ii) that dietary mineral supplementation had a
protective effect in either diet. Here we demonstrate with male
C57BL/6 mice that diet has a much greater impact on bone structure/
function than it appears to havewith females – i.e., that bone loss occurs
more rapidly and to a greater extent in the “unhealthy” diet than in the
rodent chow diet. In spite of this, males beneﬁt from mineral supple-
mentation just as much as females.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bonr.2016.05.002.
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